Frontlight ResearchEarly access
Osteoporosis trials in China
11 of 21 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Enrolling by invitationQuanduzhong Capsules for Primary Osteoporosis
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Shanghai University of Traditional Chinese Medicine
See details and how to joinNCT07895082 - Phase 4Taking peopleRANK-ligand Inhibition to Combat Sarcopenia With Underlying Osteoporosis
- Where
- Hong Kong
- Age
- 65 years and over
- People
- 120
- Run by
- Prince of Wales Hospital, Shatin, Hong Kong
See details and how to joinNCT06643780 - No phaseNot yet taking people in ChinaRobot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients
- Where
- Linhai
- Age
- 60 years and over
- People
- 88
- Run by
- Junbo Liang
See details and how to joinNCT07639619 - Phase 2Taking peopleA Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
- Where
- Beijing
- Age
- 45 years to 80 years
- People
- 200
- Run by
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
See details and how to joinNCT07579936 - No phaseNot yet taking people in ChinaStudy on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes
- Where
- Beijing, Huai'an, Jiangxi, Kunshan
- Age
- 50 years and over
- People
- 358
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07063797 - No phaseTaking peopleStudy of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
- Where
- Beijing, Changchun, Changsha, Changzhou, Chengdu, Dalian, Dongying, Guiyang, Guizhou, Haerbin, Hangzhou, Hefei, Hohhot, Jinan, Jining, Lanzhou, Liaocheng, Nanchang, Nanjing, Ningbo, Qingdao, Shanghai, Shenzhen, Shijiazhuang, Suzhou, Taiyuan, Ürümqi, Weifang, Wenzhou, Xining, Yinchuan, Zhengzhou, Zhuhai, Zibo
- Age
- 45 years to 90 years
- People
- 2,478
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05866029 - Phase 4Not yet taking people in ChinaThe Effect of Semaglutide on Bone Health
- Where
- Xiamen
- Age
- 50 years to 75 years
- People
- 150
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07165158 - Phase 1Not yet taking people in ChinaA Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07085520 - Phase 3Taking peopleA Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
- Where
- Guizhou
- Age
- 50 years to 85 years
- People
- 278
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07062978 - No phaseTaking peoplePRevention of OsTEoporotiC FracTure 2 Pilot Study
- Where
- Changsha, Dongguan, Guangzhou, Hangzhou, Hefei, Shenzhen
- Age
- 50 years and over
- People
- 50
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06134908 - No phaseTaking peopleDevelopment and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures
- Where
- Guangzhou
- Age
- 50 years to 90 years
- People
- 560
- Run by
- The Seventh Affiliated Hospital of Sun Yat-sen University
See details and how to joinNCT06379243